- Publication 1 - Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation
- Publication 2 - Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation
- Publication 3 - Introducing sense into nonsense in treatments of human genetic diseases
- Publication 4 - The unfolded protein response affects readthrough of premature termination codons
- Publication 5 - Take it personally: how personal we reach when we are so different from each other?
- Publication 6 - The suppression of premature termination codons and the repair of splicing mutations in CFTR
- Publication 7 - Muco-Obstructive Lung Diseases
- Publication 8 - Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation
- Publication 9 - Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients
Menu